Humira filed for juvenile idiopathic arthritis in Japan
This article was originally published in Scrip
Executive Summary
Abbott's TNF alpha-targeting antibody Humira (adalimumab) has been filed in Japan for the additional indication of juvenile idiopathic arthritis (JIA).